EMEA-001606-PIP02-14 - paediatric investigation plan

calcipotriol

Key facts

• Active substance:
  calcipotriol
• Therapeutic area:
  Dermatology
• Decision number:
  P/0153/2015
• PIP number:
  EMEA-001606-PIP02-14
• Pharmaceutical form(s):
  Medicated nail lacquer
• Condition(s) / indication(s):
  Treatment of psoriasis
• Route(s) of administration:
  Cutaneous use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  10/07/2015
• Compliance check done:
  No

Decision

P/0153/2015: EMA decision of 10 July 2015 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for calcipotriol (EMEA-001606-PIP02-14)

Adopted Reference Number: EMA/382980/2015 Summary:

This Decision does not constitute entitlement to the rewards and incentives referred to in Title V of Regulation (EC) No 1901/2006.